279 related articles for article (PubMed ID: 21210816)
1. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
Wang R; Zhang M; Zhou W; Ly PT; Cai F; Song W
J Neurochem; 2011 Mar; 116(6):1160-70. PubMed ID: 21210816
[TBL] [Abstract][Full Text] [Related]
2. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
Zhang H; Sun Y; Hu R; Luo W; Mao X; Zhao Z; Chen Q; Zhang Z
Cell Signal; 2013 Jul; 25(7):1574-85. PubMed ID: 23567262
[TBL] [Abstract][Full Text] [Related]
3. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis.
Zhang H; Mao X; Sun Y; Hu R; Luo W; Zhao Z; Chen Q; Zhang Z
Mol Med Rep; 2015 Aug; 12(2):2893-901. PubMed ID: 25976522
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Carboxyl Terminal Hydrolase L1 Attenuates TNF-α-Mediated Vascular Smooth Muscle Cell Migration Through Suppression of NF-κB Activation.
Gao X; Wu L; Wang K; Zhou X; Duan M; Wang X; Zhang Z; Liu X
Int Heart J; 2018 Nov; 59(6):1409-1415. PubMed ID: 30305579
[TBL] [Abstract][Full Text] [Related]
5. Aβ1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation.
Guglielmotto M; Monteleone D; Boido M; Piras A; Giliberto L; Borghi R; Vercelli A; Fornaro M; Tabaton M; Tamagno E
Aging Cell; 2012 Oct; 11(5):834-44. PubMed ID: 22726800
[TBL] [Abstract][Full Text] [Related]
6. UCH-L1 mitigates neurotoxicity induced by ZnO particles via stabilizing the inhibitor of NF-kappa B signaling, IκB-α.
Tian L; Wang K; Liu H; Li K; Lin B; Fang Z; Han J; Li N; Yang H; Bian L; Liu X; Xi Z
Ecotoxicol Environ Saf; 2019 Sep; 180():259-268. PubMed ID: 31096129
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.
Guo YY; Lu Y; Zheng Y; Chen XR; Dong JL; Yuan RR; Huang SH; Yu H; Wang Y; Chen ZY; Su B
J Neurosci; 2017 Jun; 37(25):5978-5995. PubMed ID: 28500221
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
[TBL] [Abstract][Full Text] [Related]
10. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.
Sun L; Zou LX; Han YC; Zhu DD; Chen T; Wang J
Clin Exp Nephrol; 2020 Feb; 24(2):107-118. PubMed ID: 31811410
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.
Osaka H; Wang YL; Takada K; Takizawa S; Setsuie R; Li H; Sato Y; Nishikawa K; Sun YJ; Sakurai M; Harada T; Hara Y; Kimura I; Chiba S; Namikawa K; Kiyama H; Noda M; Aoki S; Wada K
Hum Mol Genet; 2003 Aug; 12(16):1945-58. PubMed ID: 12913066
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin carboxyl terminal hydrolase L1 negatively regulates TNFalpha-mediated vascular smooth muscle cell proliferation via suppressing ERK activation.
Ichikawa T; Li J; Dong X; Potts JD; Tang DQ; Li DS; Cui T
Biochem Biophys Res Commun; 2010 Jan; 391(1):852-6. PubMed ID: 19945429
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.
El Gazzar MA; El Mezayen R; Nicolls MR; Dreskin SC
Biochim Biophys Acta; 2007 Apr; 1770(4):556-64. PubMed ID: 17292554
[TBL] [Abstract][Full Text] [Related]
16. β-Amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1.
Poon WW; Carlos AJ; Aguilar BL; Berchtold NC; Kawano CK; Zograbyan V; Yaopruke T; Shelanski M; Cotman CW
J Biol Chem; 2013 Jun; 288(23):16937-16948. PubMed ID: 23599427
[TBL] [Abstract][Full Text] [Related]
17. Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1.
Cartier AE; Djakovic SN; Salehi A; Wilson SM; Masliah E; Patrick GN
J Neurosci; 2009 Jun; 29(24):7857-68. PubMed ID: 19535597
[TBL] [Abstract][Full Text] [Related]
18. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
McKeon JE; Sha D; Li L; Chin LS
Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
[TBL] [Abstract][Full Text] [Related]
19. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.
Ogawa K; Chen F; Kuang C; Chen Y
Biochem J; 2004 Jul; 381(Pt 2):413-22. PubMed ID: 15086314
[TBL] [Abstract][Full Text] [Related]
20. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
